AlphaMark Advisors’s VYNE Therapeutics VYNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-77	Closed	-$10K	–	567
2020 Q2	$10K	Buy	77 +52	+208%	+$6.75K	﹤0.01%	368
2020 Q1	$5K	Buy	+25	New	+$5K	﹤0.01%	386